Jul 24, 2026 08:31AM
Jul 24, 2026 08:30AM
Mar 18, 2026 09:00AM
Mar 9, 2026 02:10AM
Mar 6, 2026 08:45AM
Mar 2, 2026 01:10AM
Feb 20, 2026 02:00AM FDA approves Genentech's Venclexta plus acalabrutinib for CLL treatment
Feb 20, 2026 02:00AM
Feb 20, 2026 01:05AM
Feb 16, 2026 05:31PM
Feb 16, 2026 01:00AM
Feb 7, 2026 03:40PM
Dec 22, 2025 01:01AM
Dec 22, 2025 01:00AM FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
Dec 16, 2025 08:30AM
Dec 8, 2025 04:30PM
Nov 10, 2025 01:10AM
Nov 3, 2025 09:00AM
Nov 3, 2025 01:00AM
Oct 28, 2025 02:00AM
Oct 20, 2025 01:05AM Genentech’s Tecentriq Showed Significant Overall and Disease-Free Survival Benefits in Bladder Cancer With ctDNA-Guided Treatment
Oct 20, 2025 01:01AM
Oct 20, 2025 01:00AM
Oct 16, 2025 11:49AM
Oct 16, 2025 11:45AM
Oct 13, 2025 09:00AM
Oct 13, 2025 01:05AM
Oct 2, 2025 06:30PM FDA approves Genentech's Tecentriq plus lurbinectedin for lung cancer
Oct 2, 2025 06:30PM
Sep 24, 2025 02:30AM
Sep 18, 2025 10:00AM
Sep 5, 2025 01:00AM
Aug 30, 2025 10:30AM
Aug 1, 2025 02:00PM
Jul 28, 2025 01:00AM Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC
Jul 24, 2025 09:00AM
Jul 18, 2025 11:45AM
Jul 18, 2025 11:45AM
Jun 20, 2025 11:48AM
Jun 20, 2025 11:45AM
Jun 16, 2025 11:30AM
Jun 2, 2025 04:05PM Genentech’s Tecentriq Combined with Lurbinectedin Shows Significant Survival Benefit in Extensive-Stage Small Cell Lung Cancer
May 31, 2025 08:05AM
May 30, 2025 01:00AM
May 23, 2025 01:00AM
May 22, 2025 11:45AM
May 20, 2025 02:58PM
May 13, 2025 01:00AM
Apr 25, 2025 01:00AM New England Journal of Medicine Publishes Phase III Data Showing Single-dose Xofluza Significantly Reduces Influenza Virus Transmission
Apr 2, 2025 11:45AM

327,748 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All